These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29165639)

  • 1. Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets.
    Pinto Y; Buchumenski I; Levanon EY; Eisenberg E
    Nucleic Acids Res; 2018 Jan; 46(1):71-82. PubMed ID: 29165639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Landscape of tissue-specific RNA Editome provides insight into co-regulated and altered gene expression in pigs (
    Adetula AA; Fan X; Zhang Y; Yao Y; Yan J; Chen M; Tang Y; Liu Y; Yi G; Li K; Tang Z
    RNA Biol; 2021 Oct; 18(sup1):439-450. PubMed ID: 34314293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers.
    Gu T; Fu AQ; Bolt MJ; White KP
    JCO Clin Cancer Inform; 2019 Jun; 3():1-8. PubMed ID: 31162949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
    Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
    Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
    Wang Y; Xu X; Yu S; Jeong KJ; Zhou Z; Han L; Tsang YH; Li J; Chen H; Mangala LS; Yuan Y; Eterovic AK; Lu Y; Sood AK; Scott KL; Mills GB; Liang H
    Genome Res; 2017 Jul; 27(7):1112-1125. PubMed ID: 28411194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of canonical A-to-G editing events at 3' UTRs and microRNA target sites in human lungs using next-generation sequencing.
    Soundararajan R; Stearns TM; Griswold AL; Mehta A; Czachor A; Fukumoto J; Lockey RF; King BL; Kolliputi N
    Oncotarget; 2015 Nov; 6(34):35726-36. PubMed ID: 26486088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conserved microRNA editing in mammalian evolution, development and disease.
    Warnefors M; Liechti A; Halbert J; Valloton D; Kaessmann H
    Genome Biol; 2014 Jun; 15(6):R83. PubMed ID: 24964909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer.
    Tassinari V; Cesarini V; Silvestris DA; Gallo A
    Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):291-300. PubMed ID: 30605729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs.
    Kawahara Y; Zinshteyn B; Sethupathy P; Iizasa H; Hatzigeorgiou AG; Nishikura K
    Science; 2007 Feb; 315(5815):1137-40. PubMed ID: 17322061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
    Yuting K; Ding D; Iizasa H
    Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.
    Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M
    J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and fate of microRNA editing in human brain.
    Kawahara Y; Megraw M; Kreider E; Iizasa H; Valente L; Hatzigeorgiou AG; Nishikura K
    Nucleic Acids Res; 2008 Sep; 36(16):5270-80. PubMed ID: 18684997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of human small RNA sequencing data provides insights into expression profiles and miRNA editing.
    Gong J; Wu Y; Zhang X; Liao Y; Sibanda VL; Liu W; Guo AY
    RNA Biol; 2014; 11(11):1375-85. PubMed ID: 25692236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
    Nakano M; Fukami T; Gotoh S; Nakajima M
    J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic identification of edited microRNAs in the human brain.
    Alon S; Mor E; Vigneault F; Church GM; Locatelli F; Galeano F; Gallo A; Shomron N; Eisenberg E
    Genome Res; 2012 Aug; 22(8):1533-40. PubMed ID: 22499667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA Editing Detection and Function: A Combined In Silico and Experimental Approach for the Identification and Validation of Putative Oncogenic Targets.
    Tassinari V; Cesarini V; Silvestris DA; Scafidi A; Cucina L; Gallo A
    Methods Mol Biol; 2021; 2181():253-267. PubMed ID: 32729085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The landscape of miRNA editing in animals and its impact on miRNA biogenesis and targeting.
    Li L; Song Y; Shi X; Liu J; Xiong S; Chen W; Fu Q; Huang Z; Gu N; Zhang R
    Genome Res; 2018 Jan; 28(1):132-143. PubMed ID: 29233923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA editing of human microRNAs.
    Blow MJ; Grocock RJ; van Dongen S; Enright AJ; Dicks E; Futreal PA; Wooster R; Stratton MR
    Genome Biol; 2006; 7(4):R27. PubMed ID: 16594986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A-to-I RNA editing shows dramatic up-regulation in osteosarcoma and broadly regulates tumor-related genes by altering microRNA target regions.
    Ge F; Cao X; Jiang Y
    J Appl Genet; 2023 Sep; 64(3):493-505. PubMed ID: 37542613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-EdiTar: a database of predicted A-to-I edited miRNA target sites.
    Laganà A; Paone A; Veneziano D; Cascione L; Gasparini P; Carasi S; Russo F; Nigita G; Macca V; Giugno R; Pulvirenti A; Shasha D; Ferro A; Croce CM
    Bioinformatics; 2012 Dec; 28(23):3166-8. PubMed ID: 23044546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.